Search

Your search keyword '"Alyea E"' showing total 481 results

Search Constraints

Start Over You searched for: Author "Alyea E" Remove constraint Author: "Alyea E"
481 results on '"Alyea E"'

Search Results

10. Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

16. Study of single muons with the Large Volume Detector at the Gran Sasso Laboratory

24. First observation of high-energy cosmic-ray events obtained in coincidence between EAS-TOP and LVD at Gran Sasso

25. The most powerful scintillator supernovae detector: LVD

27. A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

28. The exclusive channel π-π-π+p in π-p interactions at 147 GeV/c

31. Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation

32. An energy signature for very deep underground muons observed by the LVD experiment

33. Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome

35. Neutrino-induced and Atmospheric Single-muon Fluxes Measured Over 5 Decades of Intensity By Lvd At Gran-sasso-laboratory

36. Ex Vivo Treatment of Hematopoietic Stem Cells With 16,16-Dimethyl Prostaglandin E2 (FT1050) Improves Engraftment and Hematopoietic Reconstitution

37. Immune Reconstitution After Double Umbilical Cord Blood Stem Cell Transplantation: Comparison With Peripheral Blood Stem Cell Transplantation

38. Anti-HLA Antibodies Predict Graft Failure, Time to Engraftment and Umbilical Cord Unit Dominance in Double Umbilical Cord Blood Transplantation

40. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis

42. Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens

43. Prediction of VOD Using Biomarkers of Endothelial Injury

44. Prediction of VOD Using Biomarkers of Endothelial Injury.

46. Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation

49. Vaccine-associated immune and WT-1 responses are associated with better relapse-free survival in patients with AML in remission treated with a GM-CSF secreting leukemia vaccine and autologous stem cell transplant (ASCT)

50. Rituxan for steroid-refractory chronic GVHD

Catalog

Books, media, physical & digital resources